Principal Financial Group’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
BPC
SCM
RA
AWA
KCM
EIM
ACM
Principal Financial Group's SOPH Position: Q1 2026 in Review
Principal Financial Group increased its SOPHiA GENETICS (SOPH) stake by 0.7% in Q1 2026, buying an estimated $47.7K and bringing the position to 1,409,242 shares worth $6.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1503.
Principal Financial Group first reported a position in SOPH in Q3 2021 and has held it in 19 quarters since. The position peaked at $14.4M in Q3 2021. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.
- Principal Financial Group held 1,409,242 shares of SOPHiA GENETICS worth $6.98M as of Q1 2026.
- Principal Financial Group bought 9,800 SOPHiA GENETICS shares in Q1 2026, an estimated $47.7K.
- SOPHiA GENETICS made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #1503 holding.
- Principal Financial Group first reported a position in SOPHiA GENETICS in Q3 2021 and has held it in 19 quarters since.
- Principal Financial Group's SOPHiA GENETICS position peaked at $14.4M in Q3 2021.
- 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.
Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.